Trial intelligence / Profile preview

Methylprednisolone plus methotrexate versus placebo in clinically suspect arthralgia at risk for rheumatoid arthritis

NL-OMON20145Not yet recruiting

Sponsor
Leiden University Medical Center
Start
Jan 2015
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
Countries
1
01

Overview

Randomised trial in rheumatoid arthritis (RA) comparing Methylprednisolone plus methotrexate with Placebo injection plus placebo tablets (2 arms). Planned start Jan 2015; status: not yet recruiting.

02

Drugs

methotrexatemethylprednisolone
03

Conditions

rheumatoid arthritis (RA)

Beyond the preview

Go deeper on NL-OMON20145.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON20145.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call